天龍集團(300063.SZ):深交所中止審核公司收購睿道科技事項
格隆匯8月3日丨天龍集團(300063.SZ)公佈,公司正在籌劃發行股份及支付現金購買北京睿道科技股份有限公司100%股權並募集配套資金,由於公司前期向深交所提交的該次交易申請文件中的財務數據已超過有效期,需要進行加期審計並更新申請材料所使用的相關數據,相關工作尚需時間。
2020年8月1日,公司收到了深交所中止審核通知:“2020年08月01日,廣東天龍油墨集團股份有限公司因重大資產重組申請文件中記載的財務資料已過有效期需要補充提交,本所中止其發行上市審核。”
公司將盡快推進加期審計及更新申請材料等工作,待相關工作完成後,公司將立即向深交所更新申請材料。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.